M. Poirier

Molecular dynamics simulations and structure-based rational design lead to allosteric HCV NS5B polymerase thumb pocket 2 inhibitor with picomolar cellular replicon potency.

O. Hucke, P. Bonneau, C. Brochu, 2014, Journal of medicinal chemistry.

Peptide-based inhibitors of the hepatitis C virus serine protease.

D. Lamarre, S. LaPlante, M. Poirier, 1998, Bioorganic & medicinal chemistry letters.

Inhibition of Amino Acid Incorporation in vitro by Metabolites of 2-Acetylaminofluorene and by Certain Nitroso Compounds.∗

J. Miller, E. Miller, J. Miller, 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Mechanism and regioselectivity of the cycloaddition of thiones derived from Meldrum's acid, malonates, or other dicarbonyls.

Olivier René, Y. Dory, C. Spino, 2008, The Journal of organic chemistry.

THE CARCINOGENIC ACTIVITIES OF N-HYDROXY-2-ACETYLAMINOFLUORENE AND ITS METAL CHELATES AS A FUNCTION OF RETENTION AT THE INJECTION SITE.

J. Miller, E. Miller, M. Poirier, 1965, Cancer research.

Peptidomimetic inhibitors of the human cytomegalovirus protease.

P. Bonneau, C. Yoakim, C. Chabot, 1997, Journal of medicinal chemistry.

Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity.

M. Garneau, C. Yoakim, N. Moss, 1996, Journal of medicinal chemistry.

Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease.

D. Lamarre, J. Rancourt, M. Bailey, 1998, Bioorganic & medicinal chemistry letters.

Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.

D. Lamarre, J. Rancourt, M. Bailey, 2000, Bioorganic & medicinal chemistry letters.

Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements.

J. Proudfoot, L. Tong, E. Hickey, 1999, Journal of medicinal chemistry.